Learning Objectives
- State of the art tools for early detection of disease & monitoring of molecularly targeted therapies
- Precision oncology biomarkers to guide therapeutic decision making
- Precision therapies and understanding the pathways to guide new therapies
Co-Chairs
Dr. Heather McArthur
Dr. Sumanta Kumar Pal
